Table 1.
Factors to be considered before submission of a repurposing study
| Is there experimental evidence to support the proposed mode of action and to validate any calculated data? |
Present this experimental data explicitly Distinguish carefully between measured and calculated data |
| Be careful to check cited references, to ensure they do contain experimental data and not in silico estimates | |
| Is the mode of action specifically (target or pathway) or non-specifically (physicochemical property) driven? | |
| Are the experimental activities significant? | Cell-based assay: better than 1 microM |
| Biochemical assay, better than 100 nM | |
| Virtual screening results on their own are not sufficient | |
| Is there a clear causal link between the proposed mode of action and any clinical observations? | |
| Can be it shown that the candidate should be safe and efficacious at established dosing protocols? | Compare the concentrations required for effect at the target with the NOAEL and PK parameters |